Download PDF
1 / Pages

Other users also viewed these articles

The second Mexican consensus on hepatocellular carcinoma. Part I: Epidemiology and diagnosis L.E. Cisneros-Garza; M.S. González-Huezo; C. Moctezuma-Velázquez; L. Ladrón de Guevara-Cetina; M. Vilatobá; I. García-Juárez; R. Alvarado-Reyes; G.A. Álvarez-Treviño; S. Allende-Pérez; L. Bornstein-Quevedo; G. Calderillo-Ruiz; M.A. Carrillo-Martínez; M. Castillo-Barradas; E. Cerda-Reyes; J.A. Félix-Leyva; J.A. Gabutti-Thomas; J. Guerrero-Ixtlahuac; F. Higuera-de-la-Tijera; D. Huitzil-Meléndez; E. Kimura-Hayama; P.A. López-Hernández; R. Malé-Velázquez; N. Méndez-Sánchez; M.A. Morales-Ruiz; E. Ruíz-García; J.F. Sánchez-Ávila; L. Torrecillas-Torres;
Rev Gastroenterol Mex. 2022;87:216-34
Survival analysis of the surgical treatment of hepatocellular carcinoma at a tertiary care center C. Magadan Álvarez; J.M. Olmos-Martínez; E. González Tolaretxipi; A. Lozano Najera; E. Toledo Martínez; J.C. Rodríguez Sanjuan;
Rev Gastroenterol Mex. 2024;89:323-31
Risk factors for developing hepatocellular carcinoma in patients treated with direct-acting antivirals I. Santana-Salgado; A. Bautista-Santos; R. Moreno-Alcántar;
Rev Gastroenterol Mex. 2022;87:455-61